Conference on Challenges in Sarcoma (Ccs) 2024 Expert Opinions on Non-Evidence-Based Management Aspects
Silvia Höfer(University Hospital of Zurich), Christian Rothermundt, Katrin Scheinemann(University of Lucerne), Hans Gelderblom(Leiden University Medical Center), Bernadette Liegl‐Atzwanger(Medical University of Graz), Rick L. Haas(Leiden University Medical Center), Chantal Pauli(University of Zurich), Joanna Szkandera(Medical University of Graz), Peter Reichardt(Helios Hospital Berlin-Buch), Eva Wardelmann(University Hospital Münster), Sylvie Bonvalot(Dana-Farber Cancer Institute), Aisha Miah(Institute of Cancer Research), Beata Bode‐Lesniewska(Luzerner Kantonsspital), Wolfgang G. Kunz(LMU Klinikum), Jens Jakob(Heidelberg University), Dimosthenis Andreou(Klinik und Poliklinik für Psychosomatik und Psychotherapie), Lars H. Lindner(Center for Environmental Health), Andreas Leithner(Medical University of Graz), Peter Hohenberger(Heidelberg University), Christina Fotopoulou(Imperial College London), Piotr Rutkowskip, Benedikt M. Schaarschmidt, Jendrik Hardes(Ruhrlandklinik)
Cited by 0
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k